Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Radiology · Budd-Chiari Syndrome

Navigating Your Diagnosis: Scans, Reports, and Biopsies

At a Glance

Budd-Chiari syndrome is usually evaluated first with Doppler ultrasound to check blood flow in the hepatic veins. CT or MRI may provide a clearer map, while blood tests, venography, or a transjugular biopsy help clarify the diagnosis and guide planning when needed.

Diagnosing Budd-Chiari Syndrome (BCS) is a complex process. Because the condition is rare and the anatomy is intricate, doctors use a combination of “direct signs” (seeing the actual blockage) and “indirect signs” (seeing how the liver is reacting to the blockage) to confirm the diagnosis [1][2].

Your First Look: Doppler Ultrasound

In most cases, a Doppler ultrasound is the preferred initial test. This specialized ultrasound doesn’t just take pictures; it measures the speed and direction of blood flow [3].

  • What it looks for: The radiologist checks whether your hepatic veins are “patent” (open and flowing normally). If they are nonvisualized, contain a visible clot, or show abnormal flow, it strongly suggests BCS [3][4].
  • While highly effective, ultrasound quality depends on the operator and your specific anatomy. Sometimes, the blockage is in a difficult-to-see spot [5][6].

Deep Dives: CT and MRI

If the ultrasound is unclear, or if your doctors need a highly detailed map for treatment planning, they will order a CT scan or an MRI with contrast dye [7][8].

  • CT and MRI provide a comprehensive view of the liver’s architecture. They are particularly valuable for spotting blockages in the inferior vena cava (the large vein leading to the heart) and identifying any tumors or cysts pressing on the veins from the outside [9][10].

Reading Your Imaging and Lab Reports

Radiology and lab reports can be full of medical jargon. It is best to review these with your doctor, but here are key terms you might encounter:

  • Caudate Lobe Hypertrophy: The caudate lobe is a specific part of the liver that often has its own separate blood drainage. In BCS, this lobe frequently enlarges (hypertrophy) to compensate for the other blocked veins [11][1].
  • Nutmeg Liver / Mosaic Pattern: This describes a mottled appearance on a scan. It happens when blood backs up, making the liver tissue look patchy, like the inside of a grated nutmeg seed [12][13].
  • Collateral Vessels: These are “detour” veins your body creates to bypass the blockage [1].
  • Ascites: Fluid in the abdominal cavity, a sign of high pressure in the liver [14].
  • Bilirubin and Albumin: Blood tests that measure how well your liver is functioning.
  • INR: A measure of blood clotting time. Note: If you are already taking blood thinners like warfarin, your INR will be artificially elevated, which changes how doctors interpret this number [7].

When More Testing is Needed

Sometimes, non-invasive scans are not enough to confirm the diagnosis or plan a procedure.

  1. Venography: This is an invasive, catheter-based test where an interventional radiologist threads a thin tube into your veins, injects contrast dye, and maps the anatomy directly. It allows doctors to measure the exact pressure gradients in your liver and is frequently used immediately before or during an intervention (like placing a stent) [15][16]. Like all invasive procedures, it carries risks, such as bleeding or reactions to the contrast dye.
  2. Liver Biopsy: This may be considered if the main veins look open but the doctor suspects small-vessel BCS. Because patients with BCS often have ascites and are on blood thinners, the biopsy is frequently done via the jugular vein in the neck (transjugular biopsy) to reduce bleeding risk [17][18].

Completeness Checklist: Is Your Workup Finished?

A thorough diagnostic journey for Budd-Chiari should include the following components.

  • [ ] Vascular Mapping: Clear imaging of the hepatic veins and the inferior vena cava [2].
  • [ ] Underlying Cause Testing: Blood tests directed by a hematologist to check for MPNs (like the JAK2 mutation) and other clotting disorders [7][19].
  • [ ] Liver Function Assessment: Blood work to evaluate how well the liver is compensating [7].
  • [ ] Severity and Prognostic Scoring: Doctors may calculate scores like MELD or Child-Pugh. While these scores help describe prognosis, they do not dictate your treatment on their own; your team combines these scores with your symptoms and anatomy to make decisions [20].
  • [ ] Complication Screening: An evaluation for enlarged veins in the esophagus (varices) or fluid in the abdomen [7].

Common questions in this guide

What test is usually used first to diagnose Budd-Chiari syndrome?
Doppler ultrasound is usually the first imaging test because it shows whether blood is moving normally through the hepatic veins. A blocked, hard-to-see, or unusually flowing vein can support the diagnosis, although the result depends on the quality of the scan and the anatomy.
When would I need a CT scan or MRI for Budd-Chiari syndrome?
Doctors may order a contrast CT or MRI when Doppler ultrasound is unclear or when they need a detailed map for planning treatment. These scans can show blockages in the hepatic veins or inferior vena cava and may identify a tumor or cyst pressing on a vein.
What do caudate lobe enlargement and collateral vessels mean?
In Budd-Chiari syndrome, the caudate lobe may enlarge because it has a separate drainage pathway and can compensate for blocked veins. Collateral vessels are detour veins that form around the blockage; these findings can support liver venous congestion but must be interpreted with the full scan and clinical picture.
Why might venography or a liver biopsy be recommended?
Venography uses a catheter and contrast dye to map the veins and measure pressure, often before or during an intervention such as stent placement. If the larger veins look open but small-vessel Budd-Chiari is suspected, a transjugular liver biopsy may help; this route can reduce bleeding risk in people with ascites or who take blood thinners.
Which blood tests and scores are part of a Budd-Chiari workup?
Blood tests may assess bilirubin, albumin, liver function, and INR; warfarin can raise INR and change how it is interpreted. Additional testing can look for myeloproliferative neoplasms, JAK2 mutation, or other clotting disorders. MELD and Child-Pugh scores help describe severity and prognosis, but doctors use them with symptoms and vein anatomy rather than making treatment decisions from the scores alone.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my imaging report mention the 'patency' or flow of each of the three main hepatic veins and the inferior vena cava?
  2. 2.Is my caudate lobe enlarged, and if so, how does that affect the interpretation of my scan?
  3. 3.If my ultrasound is inconclusive, should we proceed to an MRI or CT to get a better anatomical map?
  4. 4.What are my MELD and Child-Pugh scores, and how do they combine with my symptoms to guide our treatment plan?
  5. 5.Are there any signs of collateral circulation or a 'nutmeg' pattern that support a diagnosis of liver congestion?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Diagnosis of Budd-Chiari syndrome.

    Van Wettere M, Bruno O, Rautou PE, et al.

    Abdominal radiology (New York) 2018; (43(8)):1896-1907 doi:10.1007/s00261-017-1447-2.

    PMID: 29285598
  2. 2

    Budd-Chiari syndrome: an update on imaging features.

    Faraoun SA, Boudjella Mel A, Debzi N, et al.

    Clinical imaging 2016; (40(4)):637-46.

    PMID: 27317208
  3. 3

    [Budd-Chiari syndrome, review and illustration].

    Wiest I, Teufel A, Ebert MP, et al.

    Zeitschrift fur Gastroenterologie 2022; (60(9)):1335-1345 doi:10.1055/a-1645-2760.

    PMID: 34820810
  4. 4

    Ultrasound Characteristics of Budd-Chiari Syndrome: A Multicenter Analysis.

    Daza J, Wiest I, Cui XW, et al.

    Digestive diseases (Basel, Switzerland) 2026; (44(2)):192-205 doi:10.1159/000549007.

    PMID: 41729746
  5. 5

    A Comparative Study of Ultrasonography and CT Venography in the Diagnosis of Budd-Chiari Syndrome.

    Jiang T, Qu M, Zhang Q, et al.

    Journal of clinical ultrasound : JCU 2026; (54(4)):904-914 doi:10.1002/jcu.70136.

    PMID: 41299854
  6. 6

    A Rare Association of Epstein-Barr Virus and Budd-Chiari Syndrome.

    Zaher EA, Ebrahim MA, Patel P, et al.

    Cureus 2024; (16(1)):e52323 doi:10.7759/cureus.52323.

    PMID: 38361703
  7. 7

    Budd-Chiari syndrome: investigation, treatment and outcomes.

    Goel RM, Johnston EL, Patel KV, Wong T

    Postgraduate medical journal 2015; (91(1082)):692-7 doi:10.1136/postgradmedj-2015-133402.

    PMID: 26494427
  8. 8

    Diagnostic accuracy of Doppler ultrasound, CT and MRI in Budd Chiari syndrome: systematic review and meta-analysis.

    Gupta P, Bansal V, Kumar-M P, et al.

    The British journal of radiology 2020; (93(1109)):20190847 doi:10.1259/bjr.20190847.

    PMID: 32150462
  9. 9

    A single-center retrospective study: Clinical features of different types of Budd-Chiari syndrome in Chinese patients in the Hubei area.

    Li G, Huang Y, Tang S, et al.

    Vascular 2018; (26(1)):80-89 doi:10.1177/1708538117718638.

    PMID: 28738751
  10. 10

    Characteristics of hepatocellular carcinoma in Egyptian patients with primary Budd-Chiari syndrome.

    Sakr M, Abdelhakam SM, Dabbous H, et al.

    Liver international : official journal of the International Association for the Study of the Liver 2017; (37(3)):415-422 doi:10.1111/liv.13219.

    PMID: 27507647
  11. 11

    Pattern of Vascular Involvement in Egyptian Patients with Budd-Chiari Syndrome: Relation to Etiology and Impact on Clinical Presentation.

    A Sakr M, Abdelhakam SM, Dabbous HM, et al.

    Annals of hepatology 2018; (17(4)):638-644 doi:10.5604/01.3001.0012.0933.

    PMID: 29893705
  12. 12

    Hepatic sinusoidal dilatation.

    Brancatelli G, Furlan A, Calandra A, Dioguardi Burgio M

    Abdominal radiology (New York) 2018; (43(8)):2011-2022 doi:10.1007/s00261-018-1465-8.

    PMID: 29392360
  13. 13

    Living donor liver transplantation on pediatric patient with Budd-Chiari syndrome: Case report and literature review.

    Rahayatri TH, Ruslie J, Kasahara M

    International journal of surgery case reports 2024; (115()):109294 doi:10.1016/j.ijscr.2024.109294.

    PMID: 38290357
  14. 14

    A rare pediatric case: Budd-Chiari Syndrome and upper gastrointestinal bleeding in a 5-year-old boy.

    Ibrahim MI, Egge AAA, Elmi OA, et al.

    International journal of surgery case reports 2025; (127()):110992 doi:10.1016/j.ijscr.2025.110992.

    PMID: 39889650
  15. 15

    Endovascular stenting of chronic retrohepatic inferior vena cava interruption in Budd-Chiari syndrome.

    Mathur T, Tabesh A, Kolli KP, Aarabi S

    Journal of vascular surgery cases and innovative techniques 2026; (12(4)):102296 doi:10.1016/j.jvscit.2026.102296.

    PMID: 42255370
  16. 16

    Small Intrahepatic Vein Budd-Chiari Syndrome Complicated by Fusobacterium nucleatum Peritonitis.

    Bannaga A, Armstrong MJ, Mehrzad H, et al.

    ACG case reports journal 2019; (6(7)):e00121 doi:10.14309/crj.0000000000000121.

    PMID: 31620521
  17. 17

    Small hepatic veins Budd-Chiari syndrome and paroxysmal nocturnal hemoglobinuria - The association of two rare entities: a case report.

    Gioia S, De Santis E, Cerbelli B, et al.

    Pathologica 2020; (112(2)):102-104 doi:10.32074/1591-951X-4-20.

    PMID: 32760053
  18. 18

    Budd-Chiari syndrome: a rare and life-threatening complication of Crohn's disease.

    Simoes CC, Ghouri YA, Merwat SN, Stevenson HL

    BMJ case reports 2018; (2018()) doi:10.1136/bcr-2017-222946.

    PMID: 29348288
  19. 19

    Budd-Chiari Syndrome in a patient with Multiple Hypercoagulopathies.

    Kraleti S

    The Journal of the Arkansas Medical Society 2015; (112(6)):90-1.

    PMID: 26552285
  20. 20

    Single-Center Retrospective Study of Clinical and Laboratory Features That Predict Survival of Patients With Budd-Chiari Syndrome After Liver Transplant.

    Jeschke B, Gottlieb A, Sowa JP, et al.

    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2019; (17(5)):665-672 doi:10.6002/ect.2018.0274.

    PMID: 31050620

This page is for informational purposes only and does not constitute medical advice. Your hepatologist, radiologist, or hematologist should interpret your Budd-Chiari results and recommend next steps.

Get notified when new evidence is published on hepatic vein thrombosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.